Increasing numbers of antibodies have been discovered in patients with MG, including MuSK antibodies, LRP4 antibodies, agrin antibodies, titin antibodies, potassium voltage-gated channel subfamily A member 4 (KV1.4) antibodies, ryanodine receptor antibodies, and others (4). Here, LRP4 is linked to myasthenia gravis.